D.E. Shaw & Co’s Aptose Biosciences APTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-174
Closed -$58K – 5691
2022
Q2
$58K Sell
174
-610
-78% -$292K ﹤0.01% 4823
2022
Q1
$480K Buy
784
+197
+34% +$109K ﹤0.01% 4400
2021
Q4
$357K Buy
+587
New +$552K ﹤0.01% 4593

Other funds holding APTO

D.E. Shaw & Co's APTO Position: Q3 2022 in Review

D.E. Shaw & Co sold out of Aptose Biosciences (APTO) in Q3 2022, closing a stake of 174 shares — an estimated $58K sold.

D.E. Shaw & Co first reported a position in APTO in Q4 2021 and held it in 3 quarters. The position peaked at $480K in Q1 2022. 49 funds tracked by Wall St. Rank hold APTO as of Q3 2022.

  • D.E. Shaw & Co reported no remaining Aptose Biosciences position as of Q3 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 174 Aptose Biosciences shares in Q3 2022, an estimated $58K.
  • D.E. Shaw & Co first reported a position in Aptose Biosciences in Q4 2021 and held it in 3 quarters.
  • D.E. Shaw & Co's Aptose Biosciences position peaked at $480K in Q1 2022.
  • 49 funds tracked by Wall St. Rank held Aptose Biosciences as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.